Stock CHAMPIONS ONCOLOGY INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Champions Oncology Inc OTC Bulletin Board

Equities

US15870P1093

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Champions Oncology Inc
03-15 Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. CI
03-13 Craig-Hallum Downgrades Champions Oncology to Hold From Buy MT

Chart calendar Champions Oncology Inc

246.ogcIoQKuUTUQ47y5-s68BVJZDvI3A_PxJ4EYf09kYlA.llJOx0nEPnZbl93QmLbYRzAUdpRfVKOWXsd2PXgUVTjAND2SaJgScCeMiA~6bc1dae0a5562fddedda4145cd8f723f

Upcoming events on Champions Oncology Inc

17/07/2024 Q4 2024 Earnings Release (Projected)
15/09/2024 Q1 2025 Earnings Release (Projected)
09/12/2024 Q2 2025 Earnings Release (Projected)
17/03/2025 Q3 2025 Earnings Release (Projected)

Past events on Champions Oncology Inc

12/03/2024 20:30 Q3 2024 Earnings Call
12/03/2024 20:30 Q3 2024 Earnings Release
12/12/2023 21:30 Q2 2024 Earnings Call
12/12/2023 21:00 Q2 2024 Earnings Release
18/10/2023 Annual General Meeting
25/09/2023 Translational Oncology Symposium
13/09/2023 21:30 Q1 2024 Earnings Call
13/09/2023 21:00 Q1 2024 Earnings Release
24/07/2023 21:30 Q4 2023 Earnings Call
24/07/2023 21:00 Q4 2023 Earnings Release
18/07/2023 Japanese Association for Cancer Immunology Scientific Conference
11/07/2023 Tumor Models Scientific Conference
15/03/2023 20:30 Q3 2023 Earnings Call
15/03/2023 19:50 Q3 2023 Earnings Release
13/12/2022 21:30 Interim 2023 Earnings Call
13/12/2022 21:00 Interim 2023 Earnings Release
19/10/2022 Annual General Meeting
08/09/2022 21:30 Q1 2023 Earnings Call
08/09/2022 21:00 Q1 2023 Earnings Release
21/07/2022 21:30 FY 2022 Earnings Call

Annual results

Fiscal PeriodApril 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		27,1
25,8
4.95%		32,1
31,7
1.46%		41,0
40,5
1.32%		49,1
48,9
0.34%		53,9
53,7
0.39%
48,8

EBITDA
Million USD		Released
Forecast
Spread 		0,88
0,79
11.03%		-1,02
0,88
-215.65%		1,52
1,18
28.55%		2,21
2,80
-21.04%		-2,16
-2,04
-5.94%
-6,56

EBIT
Million USD		Released
Forecast
Spread 		0,27
0,70
-61.43%		-1,80
0,23
-868.31%		0,34
0,54
-36.82%		0,61
1,32
-53.93%		-5,26
-4,71
-11.55%
-9,50

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,23
0,24
-3.95%		-1,85
0,35
-634.78%		0,41
0,60
-31.53%		0,58
1,34
-56.39%		-5,27
-4,69
-12.36%
-9,53

Net income
Million USD		Released
Forecast
Spread 		0,13
0,70
-81.71%		-1,98
0,29
-776.37%		0,33
0,84
-60.36%		0,55
1,23
-55.48%		-5,34
-4,46
-19.53%
0,00

EPS
USD		Released
Forecast
Spread 		0,01
0,06
-83.33%		-0,17
0,03
-780%		0,02
0,06
-66.67%		0,04
0,09
-52.94%		-0,39
-0,33
-18.18%
0,00

Announcement Date15/07/1927/07/2022/07/2121/07/2224/07/23-

Quarterly results

Fiscal PeriodApril 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD		Released
Forecast
Spread 		13,2
12,5
5.81%		12,9
12,7
1.21%		13,7
13,2
4.19%		14,3
13,9
2.42%		12,8
13,1
-2.74%		13,1
12,9
1.64%		12,6
13,1
-3.85%		11,6
12,8
-9.78%		12,0
13,5
-10.81%
12,7


13,1


13,3


13,5


13,7

EBITDA
Million USD		Released
Forecast
Spread 		1,19
0,77
54.86%		0,22
0,81
-72.63%		0,23
0,40
-43.78%		0,69
0,85
-19.67%		-1,52
0,07
-2396.97%		-1,75
-1,63
-7.37%		-1,67
-1,20
-38.82%		-1,42
-1,83
22.64%		-1,66
-0,31
-433.44%
-1,71


-0,82


-0,78


-0,42


-0,63

EBIT
Million USD		Released
Forecast
Spread 		0,83
0,45
84.31%		-0,31
0,40
-177.81%		-0,28
0,01
-2403.33%		0,01
-0,04
118.58%		-2,46
-0,57
-333%		-2,52
-1,98
-27.54%		-2,55
-1,74
-47.05%		-1,96
-2,36
17.21%		-2,58
-1,15
-124.09%
-2,42


-1,57


-1,48


-1,27


-1,36

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,80
0,46
73.98%		-0,35
0,41
-184.8%		-0,30
0,02
-1561.05%		0,00
-0,04
95.31%		-2,42
-0,57
-325.41%		-2,54
-1,96
-29.53%		-2,54
-1,71
-48.16%		-2,06
-2,35
12.2%		-2,52
-1,15
-120%
-2,41


-1,56


-1,47


-1,27


-1,35

Net income
Million USD		Released
Forecast
Spread 		0,79
0,42
86.05%		-0,34
0,34
-201.47%		-0,32
0,11
-394.01%		-0,02
-0,06
71.26%		-2,44
-0,44
-454.95%		-2,56
-1,69
-51.58%		-2,57
-1,41
-81.99%		-2,07
-2,30
9.88%

















EPS
USD		Released
Forecast
Spread 		0,05
0,03
100%		-0,02
0,03
-180%		-0,02
0,01
-300%		0,00
0,01
- 		-0,18
-0,04
-414.29%		-0,19
-0,13
-52%		-0,19
-0,10
-90%		-0,15
-0,17
11.76%

















Announcement Date15/03/2221/07/2212/09/2213/12/2215/03/2324/07/2313/09/2312/12/2312/03/24-----

Upcoming sector events for Champions Oncology Inc

Today 12:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
21/05/2024 CUREVAC N.V.: Q1 2024 Earnings Release (Projected)
21/05/2024 EVOTEC SE: Q1 2024 Earnings Release
30/06/2024 IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected)
15/07/2024 06:45 ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
23/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Champions Oncology Inc

Today ALVOTECH: Q1 2024 Earnings Release
17/05/2024 07:00 BIOARCTIC AB: Q1 2024 Earnings Release
15/05/2024 21:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
14/05/2024 21:05 NUVATION BIO INC.: Q1 2024 Earnings Release
14/05/2024 12:30 ABSCI CORPORATION: Q1 2024 Earnings Release
14/05/2024 06:50 BELITE BIO, INC: Q1 2024 Earnings Release
13/05/2024 POLARIS GROUP: Q1 2024 Earnings Release
13/05/2024 21:30 AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024 12:00 APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CSBR Stock
  4. Stock
  5. Calendar Champions Oncology Inc